All ranitidine drugs recalled from the market over cancer risk

The government has recalled all ranitidine products from the Kenyan market following the discovery of impurities in the drugs used to treat ulcers. The Ministry of Health, through Pharmacy and Poisons Board, says it has received information on the contamination of ranitidine products with an impurity known as Genotoxix N-nitrosodimenthylamine